RESUMEN
Antecedentes y objetivo Es bien sabido que las terapias biológicas reducen las exacerbaciones y mejoran el tratamiento del asma grave no controlada. La administración domiciliaria de biológicos ha aumentado durante la pandemia de COVID-19, pero aún no se han identificado las características de los pacientes con asma grave no controlada que pueden beneficiarse de la administración domiciliaria de terapia biológica. Materiales y métodos Este proyecto se basa en la metodología Delphi, diseñada para alcanzar un consenso entre expertos a través de un comité científico multidisciplinar que aborda las siguientes cuestiones: características clínicas, adherencia al tratamiento, capacidad de administración del paciente o cuidador, autocuidado del paciente, relación con el profesional sanitario, preferencias del paciente y acceso al hospital. Resultados Ciento treinta y un profesionales sanitarios (neumólogos, alergólogos, enfermeros y farmacéuticos hospitalarios) cumplimentaron las dos rondas de consenso del cuestionario Delphi. Se identificaron 14 ítems como características prioritarias, siendo los cinco primeros: 1. El paciente sigue las indicaciones/recomendaciones del equipo sanitario para controlar su enfermedad. 2. El paciente es capaz de detectar cualquier deterioro de su enfermedad y de identificar los factores desencadenantes de las exacerbaciones. 3. El paciente recibe tratamiento biológico y tiene una enfermedad estable sin riesgo vital. 4. El paciente se responsabiliza de su autocuidado y 5. el paciente tiene obligaciones laborales/educativas que le impiden acudir al hospital con regularidad (AU)
Background and objective Biologic therapies are known to reduce exacerbations and improve severe uncontrolled asthma management. The at-home administration of biologics has increased during the COVID-19 pandemic, but the characteristics of severe uncontrolled asthma patients who may benefit from at-home administration of biologic therapy have yet to be identified. Materials and methods This project is based on the Delphi method, designed to reach an expert consensus through a multidisciplinary scientific committee addressing the following questions: clinical characteristics, treatment adherence, patient or caregiver administration ability, patient self-care, relationship with the healthcare professional, patient preference, and access to the hospital. Results One hundred and thirty-one healthcare professionals (pulmonologists, allergists, nurses, and hospital pharmacists) completed two Delphi consensus questionnaires. Fourteen items were identified as priority characteristics, the first five being: 1. The patient follows the healthcare team's indications/recommendations to control their disease, 2. The patient is capable of detecting any deterioration in their disease and of identifying exacerbation triggers, 3. The patient receives biologic therapy and has stable disease with no vital risk, 4. The patient takes responsibility for their self-care, 5. The patient has occupational/educational obligations that prevent them from going to the hospital regularly. Conclusions Disease stability and control plus the ability to identify exacerbation triggers are the most important characteristics when opting for at-home administration for a patient with severe uncontrolled asthma on biologic therapy. These recommendations could be applicable in clinical practice (AU)
Asunto(s)
Humanos , Asma/diagnóstico , Asma/tratamiento farmacológico , Productos Biológicos/uso terapéutico , Infecciones por Coronavirus , Pandemias , Índice de Severidad de la Enfermedad , Técnica Delphi , ConsensoAsunto(s)
Humanos , Asma , Consulta Remota , Infecciones por Coronavirus , Pandemias , Índice de Severidad de la EnfermedadRESUMEN
BACKGROUND AND OBJECTIVE: Biologic therapies are known to reduce exacerbations and improve severe uncontrolled asthma management. The at-home administration of biologics has increased during the COVID-19 pandemic, but the characteristics of severe uncontrolled asthma patients who may benefit from at-home administration of biologic therapy have yet to be identified. MATERIALS AND METHODS: This project is based on the Delphi method, designed to reach an expert consensus through a multidisciplinary scientific committee addressing the following questions: clinical characteristics, treatment adherence, patient or caregiver administration ability, patient self-care, relationship with the healthcare professional, patient preference, and access to the hospital. RESULTS: One hundred and thirty-one healthcare professionals (pulmonologists, allergists, nurses, and hospital pharmacists) completed two Delphi consensus questionnaires. Fourteen items were identified as priority characteristics, the first five being: 1. The patient follows the healthcare team's indications/recommendations to control their disease, 2. The patient is capable of detecting any deterioration in their disease and of identifying exacerbation triggers, 3. The patient receives biologic therapy and has stable disease with no vital risk, 4. The patient takes responsibility for their self-care, 5. The patient has occupational/educational obligations that prevent them from going to the hospital regularly. CONCLUSION: Disease stability and control plus the ability to identify exacerbation triggers are the most important characteristics when opting for at-home administration for a patient with severe uncontrolled asthma on biologic therapy. These recommendations could be applicable in clinical practice.
Asunto(s)
Asma , Productos Biológicos , COVID-19 , Humanos , Consenso , Pandemias , Asma/diagnóstico , Asma/tratamiento farmacológico , Productos Biológicos/uso terapéuticoRESUMEN
STUDY OBJECTIVE: There is very limited information about the effect of continuous positive airway pressure (CPAP) in the very elderly. Here we aimed to analysed the effect of CPAP on a clinical cohort of patients with obstructive sleep apnea (OSA) ≥80 years old. METHODS: Post-hoc pooled analysis of two open-label, multicenter clinical trials aimed to determine the effect of CPAP in a consecutive clinical cohort of elderly (≥70 years old) with moderate-to-severe OSA (apnea-hipopnea index ≥15 events/hour) randomized to receive CPAP or no CPAP for three months. Those consecutive patients ≥80 years old were included in the study. The primary endpoint was the change in Epworth Sleepiness scale (ESS). Secondary outcomes included sleep-related symptoms, quality of life, neurocognitive and mood status as well as office blood pressure measurements. RESULTS: From the initial 369 randomized individuals with ≥70 years, 97 (26.3%) with ≥80 years old were included (47 in the CPAP group and 50 in the no-CPAP group). The mean (SD) age was 81.5 (2.4) years. Average use of CPAP was 4.3 (2.6) hours/night (53% with good adherence) Patients in the CPAP group significantly improved snoring and witnessed apneas as well as AHI (from 41.9 to 4.9 events/hour). However no clinical improvements were seen in ESS (-1.2 points, 95%CI, 0.2 to -2.6), any domain of QSQ, any neurocognitive test, OSA-related symptoms, depression/anxiety or blood pressure levels. CONCLUSIONS: The present study does not support the use of CPAP in very elderly patients with moderate-to-severe OSA.
Asunto(s)
Presión de las Vías Aéreas Positiva Contínua , Apnea Obstructiva del Sueño , Anciano , Anciano de 80 o más Años , Presión de las Vías Aéreas Positiva Contínua/métodos , Humanos , Calidad de Vida , Ensayos Clínicos Controlados Aleatorios como Asunto , Apnea Obstructiva del Sueño/psicología , Apnea Obstructiva del Sueño/terapia , RonquidoRESUMEN
BACKGROUND: Some studies have suggested a relationship between type 2 diabetes mellitus (T2DM) and increased incidence of melanoma. Efforts are under way to identify preventable and treatable factors associated with greater melanoma aggressiveness, but no studies to date have examined the relationship between T2DM and the aggressiveness of cutaneous melanoma at diagnosis. OBJECTIVES: To explore potential associations between T2DM, glycaemic control and metformin treatment and the aggressiveness of cutaneous melanoma. METHODS: We conducted a cross-sectional multicentric study in 443 patients diagnosed with cutaneous melanoma. At diagnosis, all patients completed a standardized protocol, and a fasting blood sample was extracted to analyse their glucose levels, glycated haemoglobin concentration and markers of systemic inflammation. Melanoma characteristics and aggressiveness factors [Breslow thickness, ulceration, tumour mitotic rate (TMR), sentinel lymph node (SLN) involvement and tumour stage] were also recorded. RESULTS: The mean (SD) age of the patients was 55·98 (15·3) years and 50·6% were male. The median Breslow thickness was 0·85 mm. In total, 48 (10·8%) patients were diagnosed with T2DM and this finding was associated with a Breslow thickness > 2 mm [odds ratio (OR) 2·6, 95% confidence interval (CI) 1·4-4·9; P = 0·004)] and > 4 mm (OR 3·6, 95% CI 1·7-7·9; P = 0·001), TMR > 5 per mm2 (OR 4·5, 95% CI 1·4-13·7; P = 0·009), SLN involvement (OR 2·3, 95% CI 1-5·7; P = 0·038) and tumour stages III-IV (vs. I-II) (OR 3·4, 95% CI 1·6-7·4; P = 0·002), after adjusting for age, sex, obesity, alcohol intake and smoking habits. No significant associations emerged between glycated haemoglobin levels, metformin treatment and melanoma aggressiveness. CONCLUSIONS: T2DM, rather than glycaemic control and metformin treatment, is associated with increased cutaneous melanoma aggressiveness at diagnosis.
Asunto(s)
Diabetes Mellitus Tipo 2 , Melanoma , Ganglio Linfático Centinela , Neoplasias Cutáneas , Estudios Transversales , Diabetes Mellitus Tipo 2/complicaciones , Humanos , Masculino , Melanoma/epidemiología , Persona de Mediana EdadRESUMEN
Se describe el caso de una paciente joven con amiloidosis secundaria (AA) a bronquiectasias no tuberculosas y no filiadas hasta el momento del diagnóstico, como causante de enfermedad inflamatoria crónica, responsable de la producción mantenida de SAA (proteína sérica amiloide), y depósito amiloide A en los diferentes tejidos. Se discute la rareza del caso, más habitual en el contexto de otras enfermedades inflamatorias, pero como en el pasado, aún potencialmente presente en nuestros días
The case of a young patient with amyloidosis (AA) secondary to nontuberculous bronchiectasis, which was undetermined at the time of diagnosis, is described as a cause of chronic inflammatory disease, responsible for the maintained production of SAA (serum AA protein) and amyloid A deposit in different tissues. The case is argued to be rare, being more common in the context of other inflammatory diseases, but, like in the past, potentially still present today
Asunto(s)
Humanos , Femenino , Persona de Mediana Edad , Amiloidosis/etiología , Bronquiectasia/complicaciones , Amiloidosis/patología , Proteína Amiloide A Sérica/análisis , Diagnóstico Diferencial , Tomografía Computarizada por Rayos X , Broncoscopía/métodos , Tórax/diagnóstico por imagen , Tórax/patologíaRESUMEN
Se describe el caso de una paciente de 93 años que fue ingresada por mesotelioma pleural de tipo linfoepitelial, atribuido a la exposición indirecta a fibras de asbesto procedente del lavado de la ropa de su marido, con un largo periodo de latencia. Se revisa la exposición ocupacional al asbesto y su baja incidencia en mujeres, más frecuente en estos casos por exposición indirecta o medioambiental. Se concluye con la necesidad de efectuar una correcta anamnesis para valorar los factores de riesgo de exposición, aun con largo tiempo de latencia
We describe the case of a 93-year-old patient who was diagnosed with lymphoepithelial-type pleural mesothelioma, attributed to indirect exposure to asbestos fibers from washing her husband's clothes, with a long latency period, reviewing occupational exposure to asbestos and its low incidence in women, more frequent in these cases due to indirect or environmental exposure. It concludes with the need to carry out a correct anamnesis to assess the risk factors of exposure even with a long latency time
Asunto(s)
Humanos , Femenino , Anciano de 80 o más Años , Neoplasias Pleurales/diagnóstico por imagen , Neoplasias Pleurales/inducido químicamente , Exposición a Riesgos Ambientales , Amianto/efectos adversos , Angiografía por Tomografía Computarizada , Tomografía Computarizada por Rayos X , Factores de TiempoRESUMEN
No disponible
Asunto(s)
Humanos , Fumar/terapia , Cese del Hábito de Fumar/métodos , Nebulizadores y Vaporizadores , Dispositivos para Dejar de Fumar Tabaco , Sociedades MédicasRESUMEN
No disponible
Asunto(s)
Humanos , Masculino , Femenino , Embalaje de Productos/legislación & jurisprudencia , Embalaje de Productos/métodos , Contaminación por Humo de Tabaco/legislación & jurisprudencia , Fumar/legislación & jurisprudencia , Prevención del Hábito de Fumar , Prevención del Hábito de Fumar , Embalaje de Productos/normas , Embalaje de Productos/tendenciasRESUMEN
The aim of this study to evaluate the efficacy of a home-based programme on clinical response, continuous positive airway pressure (CPAP) compliance and cost in a population of high pre-test probability of suffering obstructive sleep apnoea syndrome (OSAS). Patients were randomised into the following three groups. Group A: home respiratory polygraphy (RP) and home follow-up; group B: hospital polysomnography and hospital follow-up; and group C: home RP and hospital follow-up. Evaluation during 6 months included Epworth Sleepiness Scale (ESS), Functional Outcomes Sleep Questionnaire (FOSQ), and daily activity and symptom questionnaires. Compliance was assessed by memory cards (group A) and using an hourly counter (groups B and C). 66 patients were included (22 per branch), 83% were males, aged mean±sd 52±10 yrs, body mass index 34±7kg·m(-2), apnoea/hypopnoea index 43±20 h(-1), CPAP pressure 8±2 cmH(2)O, with no between-group differences. Clinical response showed an ESS of mean±sd 15±3 to 6±4, a FOSQ of 16±3 to 18±2, symptoms of 43±7 to 25±7, and activity of 37±11 to 25±8. At the end of the study, compliance was: group A 73%, group B 68% and group C 57%. The cost per patient was: group A 590±43, group B 894±11 and group C 644±93 (p<0.001). In conclusion, patients with a high initial probability of having OSAS can be diagnosed and treated in a home setting, with a high level of CPAP compliance and lower cost than using either a hospital-based approach or home RP/hospital follow-up.
Asunto(s)
Atención Ambulatoria/métodos , Presión de las Vías Aéreas Positiva Contínua/métodos , Servicios de Atención de Salud a Domicilio , Polisomnografía , Apnea Obstructiva del Sueño/diagnóstico , Apnea Obstructiva del Sueño/terapia , Adulto , Presión de las Vías Aéreas Positiva Contínua/enfermería , Femenino , Estudios de Seguimiento , Humanos , Masculino , Persona de Mediana Edad , Cooperación del Paciente , Polisomnografía/enfermería , Apnea Obstructiva del Sueño/enfermería , Encuestas y CuestionariosRESUMEN
BACKGROUND: Various methods have been described for safely performing fiberoptic bronchoscopy (FB) while applying non-invasive positive pressure ventilation (NIPPV) in patients with acute respiratory failure (ARF). OBJECTIVES: To evaluate the safety of a new method to perform FB in patients with ARF. METHODS: Patients with ARF in whom FB was indicated were studied. The primary end-point was a mean drop in oxygen saturation (S(a)O(2)) after the procedure. During nasal NIPPV, FB was performed via the mouth using a bite block sealed with an elastic glove finger allowing bronchoscope insertion. RESULTS: Thirty-five patients were included in the final study (63 ± 17 years, 74% men, P(a)O(2)/F(i)O(2) ratio 168 ± 63). A total of 35 bronchoaspirates, 21 protected brushings, 11 bronchoalveolar lavages and 8 bronchial biopsies were done. The cardiorespiratory variables at the start and end of FB were: S(a)O(2) 93 ± 3 to 94 ± 5%, heart rate 95 ± 17 to 99 ± 22 b.p.m. and respiratory rate 24 ± 11 to 25 ± 11 respirations/min. The lowest S(a)O(2) value reached during the procedure was 86 ± 3% and the maximal ETCO(2) rise was 41 ± 4 mm Hg. Leakage was <50 ml/s in 32 patients. The clinical course was favorable in 66%. Invasive ventilation was necessary in 11%, 5 ± 4 days after FB. Twelve patients (33%) died 3 ± 2 days after FB as a result of their underlying disease. CONCLUSIONS: The system allowed to perform FB safely in patients with ARF. Although there is a relatively high rate of intubation and invasive mechanical ventilation due to illness severity, there was no worsening of oxygenation or complications attributable to the procedure.
Asunto(s)
Broncoscopía/instrumentación , Síndrome de Dificultad Respiratoria/diagnóstico , Adulto , Anciano , Anciano de 80 o más Años , Femenino , Tecnología de Fibra Óptica , Humanos , Masculino , Persona de Mediana Edad , Estudios ProspectivosAsunto(s)
Bronquiectasia/complicaciones , Litiasis/etiología , Adulto , Femenino , Humanos , RecurrenciaAsunto(s)
Asma/diagnóstico , Pulmón/metabolismo , Mastocitos/patología , Mastocitosis Sistémica/diagnóstico , Dolor Abdominal , Acetatos/uso terapéutico , Antiasmáticos/uso terapéutico , Antiinflamatorios/uso terapéutico , Asma/complicaciones , Asma/fisiopatología , Asma/terapia , Budesonida/uso terapéutico , Permeabilidad Capilar/efectos de los fármacos , Tos , Ciclopropanos , Diarrea , Disnea , Femenino , Humanos , Pulmón/efectos de los fármacos , Pulmón/patología , Mastocitos/efectos de los fármacos , Mastocitosis Sistémica/complicaciones , Mastocitosis Sistémica/fisiopatología , Mastocitosis Sistémica/terapia , Persona de Mediana Edad , Nedocromil/uso terapéutico , Quinolinas/uso terapéutico , SulfurosRESUMEN
A 24-year-old Moroccan man was admitted to the hospital because of a tumor of the abdominal wall, fever, and purulent sputum. Imaging tests showed the presence of a pleural effusion and tumor in the right abdominal wall. The organized collection of liquid in the mass was contiguous with the thoracic collection and that of the subphrenic space. Thoracocentesis removed purulent material suggestive of empyema. Cultures and polymerase chain reaction (PCR) tests confirmed the diagnosis of tuberculous empyema. Empyema necessitatis refers to empyema that extends into the extrapleural space through a defect in the pleural surface. Various infectious etiologies may be responsible. Tuberculous empyema necessitatis is a rare complication of tuberculosis (TB); our case is even more unusual because this condition presented as an abdominal wall abcess and the patient was immunocompetent. His only predisposing factors were his country of origin, where there is a high prevalence of TB and the delay in diagnosis due to a lack of access to health care.
Asunto(s)
Pared Abdominal/patología , Absceso/microbiología , Empiema Tuberculoso/complicaciones , Enfermedades de la Piel/patología , Pared Abdominal/microbiología , Absceso/diagnóstico por imagen , Absceso/patología , Adulto , Empiema Tuberculoso/diagnóstico , Humanos , Inmunocompetencia , Masculino , Mycobacterium tuberculosis/aislamiento & purificación , Paracentesis , Cavidad Pleural/diagnóstico por imagen , Cavidad Pleural/microbiología , Reacción en Cadena de la Polimerasa , Radiografía , Enfermedades de la Piel/microbiologíaRESUMEN
No disponible
No disponible
Asunto(s)
Femenino , Anciano , Humanos , Neumonía/microbiología , Infecciones por Bordetella/complicaciones , Bordetella bronchiseptica/patogenicidad , Enfisema Pulmonar/complicacionesRESUMEN
A new method is described for performing oral fiberoptic bronchoscopy during noninvasive ventilation through the nose. The technique was successfully applied in 2 patients suffering from acute respiratory failure. The bronchoscope was inserted through a glove finger fitted into a mouth guard. The system works as a valve and does not affect performance of the bronchoscopy procedure or the pressures administered during noninvasive ventilation. We conclude that the procedure has potential advantages over bronchoscopy through the nose and face masks or helmets, particularly for the management of secretions or in special clinical circumstances (hemoptysis or presence of foreign bodies). This method can be used to substitute for or complement other bronchoscopy techniques performed with other interfaces.